Centene Corp Files 8-K for Regulation FD Disclosure

TL;DR

Centene filed an 8-K for a Reg FD disclosure. Details TBD.

AI Summary

Centene Corporation filed an 8-K on May 29, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, dollar amounts, or dates beyond the filing date itself.

Why It Matters

This filing indicates Centene Corporation is making a public disclosure under Regulation FD, which requires companies to share material information broadly.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure without immediate financial implications mentioned.

Key Players & Entities

• CENTENE CORP (company) — Filer
• Centene Corporation (company) — Registrant

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange
• $6.80 — er share (EPS) guidance of greater than $6.80 and full year consolidated health benef
• $125 million — dicare Advantage bids) of approximately $125 million. The Company will provide additional

Filing Documents

• cnc-20240529.htm (8-K) — 37KB
• 0001071739-24-000130.txt ( ) — 162KB
• cnc-20240529.xsd (EX-101.SCH) — 2KB
• cnc-20240529_lab.xml (EX-101.LAB) — 21KB
• cnc-20240529_pre.xml (EX-101.PRE) — 12KB
• cnc-20240529_htm.xml (XML) — 3KB

01 REGULATION FD DISCLOSURE

ITEM 7.01 REGULATION FD DISCLOSURE The Company will be presenting at the Bernstein 40 th Annual Strategic Decisions Conference, which will be webcast at https://event.webcasts.com/starthere.jsp?ei=1668807&tp_key=5c9c1d110a&tp_special=8 at 8:00 a.m. Eastern Daylight Time on Friday, May 31, 2024, and will be meeting with investors thereafter. The Company expects to reaffirm the 2024 full year adjusted diluted earnings per share (EPS) guidance of greater than $6.80 and full year consolidated health benefits ratio range of 87.3% to 87.9%, as well as provide intra-quarter insight including the following: Higher than expected claims receipts during April for both the first quarter of 2024 and April 2024 dates of service in the Company's Medicaid segment. The Company's early read of May claims receipts indicates continued medical costs higher than expected in Medicaid. Just under 50% of the Company's Medicaid rate changes are expected to occur between July 1 and October 1, 2024. Continued expected strong Marketplace 2024 performance, including expected favorable 2023 risk adjustment outperformance, in the second quarter of 2024. Strong consolidated premium and service revenue and investment income performance expected in the second quarter and for the remainder of 2024. Medicare segment is on track with expectations in April 2024. The Company's adjusted diluted EPS guidance now includes a fourth quarter 2024 projected premium deficiency reserve (related to 2025 Medicare Advantage bids) of approximately $125 million. The Company will provide additional detail on its second quarter 2024 earnings call in late July. Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures in this Form 8-K as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses

Forward-Looking Statements

Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this Form 8-K are forward-looking statements.Without limiting the foregoing, forward-looking statements often use words such as "guidance," "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, competition, expected contract start dates and terms, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achieveme

View Full Filing

View this 8-K filing on SEC EDGAR